[ad_1] WOODCLIFF LAKE, N.J. July 17, 2018 / PRNewswire / – Eisai Inc. has reported positive results in the CAMELLIA-TIMI 61 clinical study on cardiovascular outcomes. This study of 12,000 patients of …
Read More »Eisai Inc. Announces Topical Positive Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Results Trial for the BELVIQ® Anti-Obesity Agent
